INTRODUCTION
Of an evolving class of enzymes involving the renin-angiotensin system, the most studied is the first angiotensin converting enzyme (ACE), which catalyzes the production of angiotensin II and renders bradykinin inactive. A polymorphism in intron 16 of the ACE gene is characterized by the presence (insertion -I) or absence (deletion -D) of a 287-bp sequence, with the highest serum ACE activity in individuals carrying the DD genotype (1) .
ACE DD genotype has been related to an increased incidence of myocardial infarction (2) , and early onset of coronary heart disease (3), independent of conventional risk factors. Increased risk of secondary events following myocardial infarction (4) , and heart failure severity (5) have been linked to the D allele.
The major symptoms of chronic heart failure (CHF) are exertional fatigue and breathlessness (6) , with poor exercise capacity being a strong and independent prognostic indicator of morbidity in CHF (7) . Aerobic exercise training improves  VO 2 peak and exercise tolerance (8) in these patients, while similar changes coupled with increases in muscular strength have been observed with resistance training (9) .
The possibility that ACE genotype may have an important role in physical performance has been inferred in both observational and intervention studies. Crosssectional studies have reported the ACE I allele to be associated with enhanced endurance exercise performance in endurance athletes (10, 11) and congestive heart failure patients (12) . However, other studies have found no relationship (13) , or a lower endurance performance in individuals with the I allele (14) . Few studies have investigated the effect of ACE genotype on the response to exercise training over time.
These have been conducted in healthy volunteers and have suggested that aerobic training may result in greater improvements in moderate intensity aerobic tolerance in those with the I allele (15). In healthy young males with the D allele, 6-9 weeks of resistance training resulted in greater strength increases (16, 17) . To date only two studies have investigated the effect of ACE genotype on the response to exercise training in patients with cardiovascular disease with discordant findings (18, 19) .
DeFoor and colleagues (18) reported that three months of aerobic training resulted in greater benefits to peak oxygen uptake in coronary artery disease (CAD) patients who were homozygous for the I allele. In contrast, a similar study found no ACE genotypedependent response to a 12 week cardiac rehabilitation program in patients following an acute myocardial infarction (19) . However, the effect of ACE genotype on the response to exercise in CHF patients has never been examined. Given the possible mechanisms by which ACE gene I/D polymorphism might influence the severity of CHF, exercise tolerance and potential consequent outcomes in CHF patients, we examined the effect of ACE genotype on the response to moderate intensity circuit resistance training in CHF patients.
MATERIALS AND METHODS

Participants.
After written informed consent, 37 patients (32 men, 5 women) with stable CHF were enrolled in the study and underwent baseline testing. Descriptive characteristics of the participants are presented in Table 1 . Using randomly generated numbers with allocation being held by a third party, patients were randomised to either 11 weeks of moderate intensity resistance training exercise (n = 19; 16 male; 3 female) or a non-training control group (n = 18; 16 male; 2 female).
Inclusion and Exclusion Criteria
Patients were included if they were at least 18 years of age with stable left ventricular systolic heart failure characterised by typical clinical features, a left ventricular ejection fraction (LVEF) < 40% (by gated blood pool scan) and New York Heart Association functional class II or III. To ensure clinical stability prior to commencement in the study, all patients were required to have been on stable (> 2 weeks) pharmacological therapy prior to study entry, and not to have had any coronary event or revascularisation procedure within the previous six months.
Patients were excluded if cardiovascular limitations were deemed to be associated with a high risk of complications from exercise testing or training. These included current angina; cardiac arrest, symptomatic or sustained ventricular tachycardia within the previous six months; exercise-induced ventricular tachycardia or systolic blood pressure drop of > 20mmHg; or musculoskeletal or respiratory problems or other co-morbidity that would affect the ability to take part in an exercise training program or that were considered to be the limiting factor for exercise.
Written informed consent was obtained from all patients prior to their entry into this study that was approved by the Human Research Ethics Committees of Austin Health and Victoria University and complied with the Declaration of Helsinki.
Exercise Testing
Peak total body oxygen consumption ( Plasma lactate levels were determined and lactate threshold calculated using a log-log transformation plot of plasma lactate concentration versus power output as previously described (21, 22) .
Unilateral (right leg) skeletal muscle strength and endurance for knee extension were assessed using an isokinetic dynamometer (MERAC, Universal, Cedar
Rapids, Iowa), with microprocessor, as described previously (9) . Briefly, strength was 
Resistance Training
Training (3 sessions per week) was undertaken in the hospital gymnasium using a multi-station hydraulic resistance training system (HydraGym, Belton, USA), arm (Repco, Melbourne, Australia) and leg cycling (Repco, Melbourne, Australia) ergometers, and a set of stairs as previously described (9 shoulder press / pull (30 s). Recovery intervals between exercises were determined as the period required to return heart rate to within 10 beats of the pre-exercise (rest)
recording. For safety reasons workload intensities were reduced if the heart rate response to a station was within 5 b.min -1 of peak heart rate. Participants began by performing a single set of each exercise at the lowest resistance on the hydraulic resistance training system while technique was trained and the safety of the patient was established. Exercise progressions were introduced by increasing resistance and the number of sets for a given exercise as has been described previously (9) .
Adherence was monitored as attendance. Adverse events were documented and patients were reviewed by their primary care physician before being permitted to continue in the study. Cardiac rate and rhythm were continuously monitored and recorded during exercise on a four channel (patient) telemetry system (prototype designed by Victoria University bioengineers, Melbourne, Australia). Patients randomized to the control group were requested not to alter their normal activities of daily living or physical activity during the 11 week experimental period. Descriptive characteristics of the training and control groups of patients are presented in Table 1 .
Blood Sampling
Blood samples for ACE genotype analysis were collected from the antecubital vein using a direct needle puncture technique. 
RESULTS
Participant Characteristics
Baseline characteristics of the participants are presented in Table 1 . A  LVEF was different in patients randomized to the control group (p = 0.035) but not the training group. When separated according to the treatment group into which they had been randomised, there were no significant differences in any descriptive characteristic (Table 1) .
Baseline Results
There was a strong correlation between peak power attained during the symptom-limited graded exercise test (PP; W) and peak aerobic power ( (Table 2 ). There was no relationship between ACE genotype and either quadriceps muscle strength or endurance in the CHF patients at baseline. Post hoc testing revealed no differences between groups randomised to either exercise or the control protocol in any measure of exercise tolerance.
Response to Training
The resistance training protocol resulted in significant improvements in 2 O V  peak and in muscle strength and endurance when the effect of training was examined regardless of genotype (9) . However, significant differences were noted between genotypes in the response to 11 weeks of resistance training and the control intervention. After accounting for differences between the genotypes at baseline, resistance training was observed to result in significantly greater increases in PP in patients with the D allele (ID and DD), compared to those who were homozygous for the I allele ( 
DISCUSSION
Major Findings
The main findings of the present study were that heart failure patients with the 
Effect of training on physical function
The genotype dependent changes in PP in response to the resistance training intervention that we observed in heart failure patients is in keeping with those of previous studies of healthy volunteers, which indicate that individuals with the D allele may be better suited to resistance or power type exercise than those homozygous for the I allele (16, 17) . It might be tempting to suggest that the changes in peak RER were responsible for the changes in PP. However while peak RER was Changes in the regulation of bradykinin may also have a role in the genotypedependent changes in PP. D allele incidence has been linked to a higher rate of bradykinin degradation (26) while chronic exercise training has been observed to result in increases in sensitivity to bradykinin in the brachial arteries of swine in vitro (27) . If this phenomenon were to occur in human vasculature in response to exercise training, it may partially account for the difference in PP noted in patients with the D allele compared to those homozygous for the I allele. The expected functional result of an elevation in circulating bradykinin after training would be increased skeletal muscle perfusion during exercise, and hence a delayed onset of lactic acidosis and fatigue. CHF patients display elevated peak lactates during exercise following a resistance training intervention compared to baseline results (21) . This result in itself may be indicative of increased muscle blood flow, allowing a greater flux of lactate from the cells into the bloodstream for full removal. However, while the mean power output at which lactate threshold occurred changed by more in the training group than the control group in the current study, the changes were not significant, nor were they genotype-dependent (Table 3 ).
14 A possible mechanism for greater improvements in muscle strength in those with the D allele involves the potential role of angiotensin II. Angiotensin II is a mediator of the hypertrophic response to mechanical loading in rodent muscle (28, 29) . The potential synergistic actions of angiotensin II in combination with mechanical loading provides a mechanism by which the previously observed (16, 17) greater increases in strength following resistance training in subjects with the D allele may have occurred.
Study Limitations.
A limitation of the current study and possible reason for the lack of genotypedependent changes in strength or 
